Table 2.
Characteristic | Total Patient Cases | Bivariate Logistic Regression |
Multivariable Logistic Regression* |
||||
---|---|---|---|---|---|---|---|
OR | 95% CI | P | OR | 95% CI | P | ||
Disease site | |||||||
Breast | 14,898 | 0.185 | 0.17 to 0.20 | < .001 | 0.423 | 0.37 to 0.48 | < .001 |
Cervix | 684 | 0.349 | 0.25 to 0.49 | < .001 | 1.440 | 0.93 to 2.24 | .1047 |
Colon | 9,060 | 0.584 | 0.54 to 0.63 | < .001 | 0.591 | 0.53 to 0.66 | < .001 |
Kidney and renal pelvis | 3,762 | 0.914 | 0.83 to 1.01 | .0768 | 1.209 | 1.06 to 1.38 | .0057 |
Lung/bronchus | |||||||
Small cell | 2,367 | 1.433 | 1.29 to 1.60 | < .001 | 1.675 | 1.45 to 1.93 | < .001 |
Non–small cell | 11,518 | 1.483 | 1.41 to 1.60 | < .001 | 2.465 | 2.28 to 2.66 | < .001 |
Melanoma | 3,859 | 0.461 | 0.41 to 0.52 | < .001 | 0.304 | 0.25 to 0.37 | < .001 |
Non-Hodgkin lymphoma | |||||||
Low grade | 1,419 | 2.095 | 1.85 to 2.40 | < .001 | 3.049 | 2.59 to 3.60 | < .001 |
High grade | 2,034 | 1.107 | 0.98 to 1.26 | 0.1091 | 1.252 | 1.07 to 1.47 | .0058 |
Prostate | 14,432 | 1.303 | 1.24 to 1.37 | < .001 | 0.953 | 0.86 to 1.05 | .3304 |
Rectum | 2,349 | 0.724 | 0.63 to 0.84 | < .001 | 1.199 | 1.01 to 1.43 | .0429 |
Other | 42,059 | Ref† | |||||
Stage of disease at diagnosis | |||||||
II | 25,141 | 2.070 | 1.93 to 2.22 | < .001 | 1.691 | 1.53 to 1.87 | < .001 |
III | 14,402 | 2.059 | 1.90 to 2.23 | < .001 | 2.725 | 2.47 to 3.01 | < .001 |
IV | 18,613 | 6.448 | 6.05 to 6.89 | < .001 | 7.964 | 7.31 to 8.68 | < .001 |
Unknown | 19,242 | 6.216 | 5.84 to 6.62 | < .001 | 4.962 | 4.57 to 5.39 | < .001 |
I | 31,043 | Ref† | |||||
Age at diagnosis, years | 1.057 | 1.06 to 1.08 | .0122 | 1.053 | 1.05 to 1.06 | < .001 | |
Sex‡ | |||||||
Female | 52,532 | 1.053 | 1.01 to 1.10 | .0164 | 0.916 | 0.88 to 0.97 | .0014 |
Male | 55,906 | Ref† | |||||
Patient residence | |||||||
Large rural city/town | 16,569 | 1.253 | 1.19 to 1.32 | < .001 | 1.193 | 1.11 to 1.28 | < .001 |
Small rural town | 20,844 | 1.106 | 1.05 to 1.16 | < .001 | 0.809 | 0.75 to 0.87 | < .001 |
Isolated small rural | 19,440 | 1.049 | 0.10 to 1.10 | .0594 | 0.750 | 0.70 to 0.81 | < .001 |
Urban | 51,582 | Ref† | |||||
Institution type | |||||||
Comprehensive or academic cancer center | 47,914 | 1.410 | 1.32 to 1.51 | < .001 | 2.975 | 2.61 to 3.39 | < .001 |
Community or integrated cancer center | 9131 | 2.135 | 1.96 to 2.33 | < .001 | 3.575 | 3.08 to 4.14 | < .001 |
PPS hospital§ | 21,064 | 2.467 | 2.30 to 2.65 | < .001 | 4.450 | 3.90 to 5.08 | < .001 |
Critical access hospital | 9788 | 3.851 | 3.56 to 4.16 | < .001 | 6.531 | 5.67 to 7.52 | < .001 |
Clinic or physician office | 3233 | 26.576 | 24.19 to 29.20 | < .001 | 81.325 | 68.97 to 95.90 | < .001 |
NCI cancer center | 17,311 | Ref† | |||||
Oncologist seen‖ | |||||||
Yes | 39,146 | 0.545 | 0.52 to 0.57 | < .001 | 0.415 | 0.39 to 0.44 | < .001 |
No | 47,771 | Ref† | |||||
Radiation therapist seen | |||||||
Yes | 24,126 | 0.173 | 0.16 to 0.19 | < .001 | 0.165 | 0.15 to 0.18 | < .001 |
No | 62,791 | Ref† | |||||
Surgeon seen | |||||||
Yes | 31,959 | 0.333 | 0.32 to 0.35 | < .001 | 0.455 | 0.43 to 0.47 | < .001 |
No | 54,958 | Ref† |
Abbreviations: NCI, National Cancer Institute; OR, odds ratio; PPS, prospective payment system; Ref, reference.
Multivariable logistic regression included all variables in the model.
Ref indicates the reference group within each bivariate and multivariable logistic regression analysis.
Bivariate analysis of sex was conducted excluding predominately sex-specific cancers (ie, breast, cervical, prostate, and uterus cancers).
Indicates PPS hospitals that are not Commission on Cancer accredited.
Oncologist includes medical, gynecologic, pediatric, and hematologic oncologists but does not include radiation oncologists.